Barclays raised the firm’s price target on Ovintiv (OVV) to $57 from $55 and keeps an Overweight rating on the shares following the Q2 report. The company reported strong execution all around, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVV:
- Ovintiv’s Strong Financial Performance and Strategic Improvements Justify Buy Rating
- Closing Bell Movers: Intel slides after quarterly report
- Ovintiv Reports Q2 2025 Results, Reduces Net Debt
- Ovintiv sees Q3 total production 610-630 MBOE/d
- Ovintiv raises 2025 total production view to 600-620 from 595-615 MBOE/d